TMS Co.,Ltd.

4891

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-14FY2026 Q2

Revenue

YoY -

Operating Income

-3.9100M JPY

YoY +16.9%

Net Income

-3.9100M JPY

YoY +41.3%

EPS

-8.6JPY

YoY +22.2%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

-2.4億円

-4.8億円

-7.2億円

-9.6億円

Rev: -Op: -5.2億円NI: -8.6億円

Rev: -Op: -9.4億円NI: -9.6億円

Rev: -Op: -9.1億円NI: -6.6億円

Rev: -Op: -7億円NI: -7.2億円

2023/FY2024/FY2025/FY2025/FY

Full-Year Progress

FY2026 Q2

Net Income-

Revenue Progress-

Revenue Forecast-

Net Income Progress-

Net Income Forecast-

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan